536 related articles for article (PubMed ID: 27511018)
1. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
Rojanathammanee L; Floden AM; Manocha GD; Combs CK
J Neuroinflammation; 2015 Mar; 12():42. PubMed ID: 25889879
[TBL] [Abstract][Full Text] [Related]
3. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
[TBL] [Abstract][Full Text] [Related]
4. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
5. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
6. The Ames dwarf mutation attenuates Alzheimer's disease phenotype of APP/PS1 mice.
Puig KL; Kulas JA; Franklin W; Rakoczy SG; Taglialatela G; Brown-Borg HM; Combs CK
Neurobiol Aging; 2016 Apr; 40():22-40. PubMed ID: 26973101
[TBL] [Abstract][Full Text] [Related]
7. NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.
Manocha GD; Ghatak A; Puig KL; Kraner SD; Norris CM; Combs CK
J Alzheimers Dis; 2017; 58(3):775-787. PubMed ID: 28505967
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-producing microglia have an altered beta-amyloid load in aged APP/PS1 Tg mice.
Babcock AA; Ilkjær L; Clausen BH; Villadsen B; Dissing-Olesen L; Bendixen AT; Lyck L; Lambertsen KL; Finsen B
Brain Behav Immun; 2015 Aug; 48():86-101. PubMed ID: 25774009
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
[TBL] [Abstract][Full Text] [Related]
10. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
[TBL] [Abstract][Full Text] [Related]
11. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
[TBL] [Abstract][Full Text] [Related]
12. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease.
Cameron B; Tse W; Lamb R; Li X; Lamb BT; Landreth GE
J Neurosci; 2012 Oct; 32(43):15112-23. PubMed ID: 23100432
[TBL] [Abstract][Full Text] [Related]
13. Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer's disease.
Horibe S; Emoto T; Mizoguchi T; Tanaka T; Kawauchi S; Sasaki N; Yamashita T; Ikeda K; Emoto N; Hirata KI; Rikitake Y
Glia; 2024 Jan; 72(1):51-68. PubMed ID: 37610154
[TBL] [Abstract][Full Text] [Related]
14. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
15. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
16. Treadmill Exercise Promotes Microglial β-Amyloid Clearance and Prevents Cognitive Decline in APP/PS1 Mice.
Liang F; Sun F; He B; Wang J
Neuroscience; 2022 May; 491():122-133. PubMed ID: 35398179
[TBL] [Abstract][Full Text] [Related]
17. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the Inflammasome Sensor Aim2 Mitigates Aβ Deposition and Microglial Activation but Increases Inflammatory Cytokine Expression in an Alzheimer Disease Mouse Model.
Wu PJ; Hung YF; Liu HY; Hsueh YP
Neuroimmunomodulation; 2017; 24(1):29-39. PubMed ID: 28618410
[TBL] [Abstract][Full Text] [Related]
19. Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer's Disease.
Manocha G; Ghatak A; Puig K; Combs C
Curr Alzheimer Res; 2018; 15(12):1123-1135. PubMed ID: 30068274
[TBL] [Abstract][Full Text] [Related]
20. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
